The Pharmaceutical Journal
Vol 270 No 7239 p326
8 March 2003

This article
Reprint
Photocopy

News summary

Related websites
MeReC Bulletin (PDF 200K)

MeReC update on PMS

Most treatments for premenstrual syndrome (PMS) are not supported by good quality evidence, the MeReC Bulletin says (2003;13:9). The bulletin suggests that drug therapy should only be considered for women with severe symptoms or PMS that is resistant to lifestyle and dietary changes.

A copy of the bulletin is included with this week’s issue of The Journal sent to all pharmacists in England.

The bulletin can also be downloaded as a PDF (200K) or via the NHSnet (nww.npc.ppa.nhs.uk).

  * PDF files on PJ Online require Acrobat Reader 4 or later